Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

Author:

Burdett Sarah1,Pignon Jean Pierre2,Tierney Jayne1,Tribodet Helene2,Stewart Lesley3,Le Pechoux Cecile4,Aupérin Anne2,Le Chevalier Thierry5,Stephens Richard J6,Arriagada Rodrigo7,Higgins Julian PT8,Johnson David H9,Van Meerbeeck Jan10,Parmar Mahesh KB6,Souhami Robert L11,Bergman Bengt12,Douillard Jean-Yves13,Dunant Ariane2,Endo Chiaki14,Girling David6,Kato Harubumi15,Keller Steven M16,Kimura Hideki17,Knuuttila Aija18,Kodama Ken19,Komaki Ritsuko20,Kris Mark G21,Lad Thomas22,Mineo Tommaso23,Piantadosi Steven24,Rosell Rafael25,Scagliotti Giorgio26,Seymour Lesley K27,Shepherd Frances A28,Sylvester Richard29,Tada Hirohito30,Tanaka Fumihiro31,Torri Valter32,Waller David33,Liang Ying34,

Affiliation:

1. MRC Clinical Trials Unit at UCL; Meta-analysis Group; Aviation House 125 Kingsway London UK WC2B 6NH

2. Gustave Roussy Cancer Campus; Plateforme LNCC de Méta-analyse en Oncologie et Service de Biostatistique et d’Epidémiologie; Villejuif France

3. University of York; Centre for Reviews and Dissemination; York UK YO10 5DD

4. Gustave Roussy Cancer Campus; Département de Radiothérapie; Villejuif France

5. Gustave Roussy Cancer Campus; Département de Médecine; 39, rue Camille Desmoulins Villejuif France 94805

6. MRC Clinical Trials Unit at UCL; Cancer Division; London UK

7. Karolinska Institutet; Stockholm Sweden

8. University of Bristol; School of Social and Community Medicine; Canynge Hall 39 Whatley Road Bristol UK BS8 2PS

9. University of Texas Southwestern Medical Center; Department of Medicine; 5323 Harry Hines Blvd Rm. G5.210 Dallas Texas USA 75390-9030

10. University Hospital,; Ghent Belgium

11. Cancer Research UK; London UK

12. Sahlgrenska Academy; Gothenberg Sweden

13. Integrated Centers of Oncology R Gauducheau; St Herblain France

14. Institute of Development, Aging and Cancer, Tohoku University; Sendai Japan

15. Tokyo Medical University; Tokyo Japan

16. Montefi ore Medical Center; New York USA

17. Chiba Cancer Center; Chiba City Japan

18. Helsinki University Central Hospital; Pulmonary Department; PO Box 340 Haartmaninkatu Helsinki Finland FIN-00290 HUS

19. Osaka Medical Center for Cancer and Cardiovascular Diseases; Osaka Japan

20. University of Texas MD Anderson Cancer Center; Houston Texas USA

21. Memorial Sloan-Kettering Cancer Center; New York USA

22. Cook County Hospital; Chicago Illinois USA

23. Policlinico Tor Vergata, University; Roma Italy

24. Cedars Sinai Medical Centre, Samuel Oschin Comprehensive Cancer Institute; Los Angeles California USA

25. Catalan Institute of Oncology, Hospital Germans Trias i Pujol; Barcelona Spain

26. S. Luigi Hospital; Turin Italy

27. Queen’s University, NCIC Clinical Trials Group; Kingston Ontario Canada

28. Princess Margaret Cancer Centre; Toronto Canada

29. European Organisation for Research and Treatment of Cancer; Data Center; Avenue E Mounier 83 - Bte 11 Brussels Belgium 1200

30. Suita Saiseikai Hospital; Suita Japan

31. University of Occupational and Environmental Health; Chest Surgery (Second Department of Surgery); Iseigaoka 1-1 Yahata-nishi-ku Kitakyusyu Fukuoka Japan 8078555

32. Mario Negri Institute; Laboratorio di Epidemiologia Clinica; Via Eritrea 62 Milano Milano Italy 20157

33. Glenfield Hospital; Leicester UK

34. Sun Yat-Sen University Cancer Center; Guangzhou China

Publisher

Wiley

Subject

Pharmacology (medical)

Reference92 articles.

1. A randomized controlled study of postoperative adjuvant chemoimmunotherapy of resected non-small cell lung cancer with IL2 and LAK cells;Kimura;Lung Cancer,1991

2. Adjuvant chemotherapy for completely resected stage III non-small cell lung cancer;Ohta;Journal of Thoracic and Cardiovascular Surgery,1993

3. Postoperative adjuvant therapy for stage IB non-small cell lung cancer;Mineo;European Journal of Cardio-Thoracic Surgery,2001

4. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer;Park;European Journal of Cardio-Thoracic Surgery,2005

5. Postoperative adjuvant therapy for stage IIIA non-small cell lung cancer;Park;Journal of Thoracic Oncology,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3